ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Verdi J. DiSesa
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohiuddin, M. M.
Right arrow Articles by DiSesa, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohiuddin, M. M.
Right arrow Articles by DiSesa, V. J.
Related Collections
Right arrow Transplantation - heart
Right arrowRelated Article

Ann Thorac Surg 2001;72:740-745
© 2001 The Society of Thoracic Surgeons


Original article: cardiovascular

Long-term survival of cardiac xenografts in fully xenogeneic (mouse -> rat) bone marrow chimeras

Muhammad M. Mohiuddin, MDa, Yong Qin, MDa, Xiaohua Qian, MD, PhDa, Yuru Meng, MDa, Verdi J. DiSesa, MDa

a Department of Cardiovascular-Thoracic Surgery, Rush Presbyterian St. Lukes Medical Center, Chicago, Illinois, USA

Accepted for publication May 1, 2001.

Address reprint requests to Dr Mohiuddin, Department of Cardiovascular-Thoracic Surgery, Rush Presbyterian St. Lukes Medical Center, 1653 W Congress Pkway, Chicago, IL 60612
e-mail: mmohiudd{at}rush.edu

Background. The shortage of human hearts remains a major barrier to the efficacy of heart transplantation for the treatment of end-stage heart disease. One potential solution to the supply problem would be the use of hearts from nonhuman donors (xenografts). We have established a model of mouse to rat xenogeneic bone marrow chimerism, and in this study we have hypothesized that such chimeric rats will accept both donor and recipient specific heart grafts while rejecting third-party mouse and rat grafts. We also investigated humoral responses in naïve and chimeric rats with and without donor murine cardiac grafts.

Methods. Recipient Lewis rats (n = 22) were given 1100 cGy lethal total body irradiation and the same day received 300 x 106 donor B10.BR mouse bone marrow cells intravenously. Peripheral blood of surviving rats (n = 18) was typed at 4 weeks and then monthly thereafter. Donor and recipient specific and third-party heterotopic heart transplantations were performed at 6 to 8 weeks after reconstitution with bone marrow.

Results. Multilineage bone marrow chimerism was produced in all experimental animals with complete replacement of recipient marrow by donor cells. Murine donor and rat recipient strain hearts transplanted in chimeric rats survived indefinitely. Third-party rat and mouse hearts were rejected, though at a slower rate than bone marrow matched naïve controls. High levels of antimouse antibodies were detected in rats with rejected hearts. These antibodies were absent in chimeric animals with long-term surviving heart grafts.

Conclusions. Long-term multilineage bone marrow chimerism can be produced in a mouse -> rat bone marrow transplant model. Long-term survival of donor specific and recipient specific vascularized cardiac grafts can be produced in these chimeric animals. These animals are clinically normal but show signs of subclinical immunosuppression regimen as they reject third-party hearts later than naïve animals. Our results suggest that antibodies also play a significant role in concordant xenograft rejection, and induction of bone marrow chimerism can overcome this barrier.


Related Article

Invited commentary
Bruce R. Rosengard
Ann. Thorac. Surg. 2001 72: 745-746. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. L. Colson, H. Xu, Y. Huang, and S. T. Ildstad
Mixed Xenogeneic Chimerism Induces Donor-Specific Humoral and Cellular Immune Tolerance for Cardiac Xenografts
J. Immunol., November 1, 2004; 173(9): 5827 - 5834.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.